Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Elite Intratumoral T-cell Clonotypes (The 1%) Effect "Trickle-Down Cytotoxicity".

Henick BS.

Clin Cancer Res. 2020 Mar 15;26(6):1205-1207. doi: 10.1158/1078-0432.CCR-19-3788. Epub 2020 Jan 9.

PMID:
31919138
2.

Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy.

Liu Y, Zugazagoitia J, Ahmed FS, Henick BS, Gettinger SN, Herbst RS, Schalper KA, Rimm DL.

Clin Cancer Res. 2020 Feb 15;26(4):970-977. doi: 10.1158/1078-0432.CCR-19-1040. Epub 2019 Oct 15.

PMID:
31615933
3.

Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer.

Zugazagoitia J, Liu Y, Toki M, McGuire J, Ahmed FS, Henick BS, Gupta R, Gettinger SN, Herbst RS, Schalper KA, Rimm DL.

J Thorac Oncol. 2019 Dec;14(12):2084-2096. doi: 10.1016/j.jtho.2019.09.014. Epub 2019 Oct 9.

PMID:
31605795
4.

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer.

Hastings K, Yu HA, Wei W, Sanchez-Vega F, DeVeaux M, Choi J, Rizvi H, Lisberg A, Truini A, Lydon CA, Liu Z, Henick BS, Wurtz A, Cai G, Plodkowski AJ, Long NM, Halpenny DF, Killam J, Oliva I, Schultz N, Riely GJ, Arcila ME, Ladanyi M, Zelterman D, Herbst RS, Goldberg SB, Awad MM, Garon EB, Gettinger S, Hellmann MD, Politi K.

Ann Oncol. 2019 Aug 1;30(8):1311-1320. doi: 10.1093/annonc/mdz141.

5.

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.

Datar I, Sanmamed MF, Wang J, Henick BS, Choi J, Badri T, Dong W, Mani N, Toki M, Mejías LD, Lozano MD, Perez-Gracia JL, Velcheti V, Hellmann MD, Gainor JF, McEachern K, Jenkins D, Syrigos K, Politi K, Gettinger S, Rimm DL, Herbst RS, Melero I, Chen L, Schalper KA.

Clin Cancer Res. 2019 Aug 1;25(15):4663-4673. doi: 10.1158/1078-0432.CCR-18-4142. Epub 2019 May 3.

PMID:
31053602
6.

The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer.

Henick BS, Herbst RS, Goldberg SB.

Expert Opin Ther Targets. 2014 Dec;18(12):1407-20. doi: 10.1517/14728222.2014.955794. Epub 2014 Oct 21. Review.

PMID:
25331677

Supplemental Content

Loading ...
Support Center